HYPOGONADISM IN METABOLIC SYNDROME PATIENTS
Journal Title: Romanian Journal of Diabetes Nutrition and Metabolic Diseases - Year 2011, Vol 18, Issue 1
Abstract
Introduction. Previous studies have shown a high prevalence of low levels of the endogenous sexual hormones in patients with metabolic syndrome (MetS). The aim of this study was to analyze the prevalence of hypogonadism in MetS patients. Materials and Methods. We analyzed the relationship between testosterone levels and components of metabolic syndrome in 381 patients. These patients were divided into two groups: group A – patients with metabolic syndrome (MetS) and hypogonadism (MetS+T) and group B – patients with metabolic syndrome without hypogonadism (MetS-T). Overweight was defined as BMI 26-29.9kg/m2. Obesity was defined as BMI≥30 kg/m2. Male hypogonadism or androgen deficiency has been defined as a maximum level of total testosterone up to 3 ng/ml. Results. There were no significant age differences between groups (59.8±8.38 versus 58.31±7.47 years p=0.06). Prevalence of hypogonadism in metabolic syndrome patients was 33.5% (n=128). There were no significant differences between groups in terms of body weight, waist circumference, hip circumference, BMI and blood pressure between groups (all p>0.05). Patients with hypogonadism had significantly higher levels of triglycerides, FPI, HOMA-IR (all p<0.05) and smaller HDL-cholesterol and SHBG (all p<0.05). There was a significant decline in testosterone concentration with increase in age and BMI. 88.3% of the diabetic patients (n=113) had hypogonadism (p=0.0001). Hypogonadism was present in 25% patients (n=32) with 3 components of MetS, 43.8% (n=56) patients with 4 componets of MetS and in 31.2% (n=40) patients with 5 components of MetS (p=0.0001). Conclusions. Hypogonadism is a common occurrence in subjects with MetS. Males with MetS with or without diabetes have lower serum testosterone. Patients with MetS should be investigated for clinical and biochemical signs of hypogonadism and patients with hypogonadism should be investigated for signs of metabolic syndrome.
Authors and Affiliations
Florin Rusu, Emilia Rusu, Gabriela Radulian, Georgiana Enache, Mariana Jinga, Viorel Jinga, Carmen Radu, Dan Mischianu, Dan Mircea Cheţa
Keywords
Related Articles
- EP ID EP155377
- DOI -
- Views 90
- Downloads 0
ANKLE BRACHIAL PRESSURE INDEX, VALUE AND LIMITATIONS CONSIDERATIONS ABOUT ITS APPLICABILITY FOR DIABETIC INDIVIDUALS
Non-invasive ultrasound investigations are frequently used as a screening maneuver for peripheral vascular disease. The ankle to brachial pressure index (ABPI) it is a noninvasive hand-held Doppler test that is able to p...
PERIOPERATIVE NUTRITIONAL STATUS
Malnutrition is defined as the pathological state in which the nutritional intake is insufficient, excessive or ill-balanced and represents a frequent problem among hospitalized patients. The risk factors involved in the...
ADVANCED GLYCATION END PRODUCTS MEASURED BY AGE READER IN A GROUP OF PATIENTS WITH OBESITY
Background and Aim: Skin autofluorescence (AF) is a method used to detect the accumulation of Advanced Glycation End Products (AGEs) in skin collagen using AGE Reader. AGEs accumulation is favorised by chronic hype...
ONCE AGAIN ABOUT HEALTHY NUTRITION AND ITS ROLE IN PREVENTION OF TYPE 2 DIABETES
THE RESUMPTION OF MENSES TROUGH REDUCTION OF WEIGHT AND TREATMENT WITH METFORMIN TO A YOUNG GIRL WITH THE POLYCYSTIC OVARY SYNDROME
Objectives: We aimed to evaluate the effect of reducing body weight by optimization of lifestyle and the utility of metformin association to a young obese woman with polycystic ovary syndrome (PCOS). Material and Method:...